Clinical Manifestations of Ocular Toxoplasmosis

被引:73
作者
Delair, Emmanuelle [3 ]
Latkany, Paul [4 ]
Noble, A. Gwendolyn [1 ,5 ]
Rabiah, Peter [1 ,2 ]
McLeod, Rima [1 ]
Brezin, Antoine [3 ]
机构
[1] Univ Chicago, Chicago, IL 60637 USA
[2] Northshore Univ Hlth Syst, Chicago, IL USA
[3] Univ Paris 05, Serv Ophtalmol, Hop Cochin, Paris, France
[4] NYU, New York Eye & Ear Inst, New York, NY USA
[5] Northwestern Univ, Childrens Mem Hosp, Chicago, IL 60614 USA
关键词
CNVM; congenital toxoplasmosis; retinal choriditis; Toxoplasma gondii; uveitis; CONGENITAL TOXOPLASMOSIS; FOLLOW-UP; CHOROIDAL NEOVASCULARIZATION; ARTERY-OCCLUSION; 327; CHILDREN; EYE LESIONS; INFANTS; PROGNOSIS; RETINOCHOROIDITIS; PYRIMETHAMINE;
D O I
10.3109/09273948.2011.564068
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Clinical manifestations of ocular toxoplasmosis are reviewed. Findings of congenital and acute acquired ocular toxoplasmosis include retinal scars, white-appearing lesions in the active phase often associated with vitritis. Complications can include fibrous bands, secondary serous or rhegmatogenous retinal detachments, optic neuritis and neuropathy, cataracts, increased intraocular pressure during active infection, and choroidal neovascular membranes. Recurrences in untreated congenital toxoplasmosis occur in teenage years. Manifestations at birth are less severe, and recurrences are fewer in those who were treated promptly early in the course of their disease in utero and in the first year of life. Severe retinal involvement is common at diagnosis of symptomatic congenital toxoplasmosis in the United States and Brazil. Acute acquired infections also may be complicated by toxoplasmic retinochoroiditis, with recurrences most common close to the time of acquisition. Suppressive treatment can reduce recurrent disease.</.
引用
收藏
页码:91 / 102
页数:12
相关论文
共 58 条
[1]   Pars plana vitrectomy for vitreoretinal complications of ocular toxoplasmosis [J].
Adan, Alfredo ;
Giralt, Joan ;
Alvarez, Guifre ;
Alforja, Socorro ;
Bures-Jesltrup, Anniken ;
Casaroli-Marano, Ricardo P. ;
Corcostegui, Borja .
EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2009, 19 (06) :1039-1043
[2]   Cataracts in congenital toxoplasmosis [J].
Arun, Veena ;
Noble, A. Gwendolyn .
JOURNAL OF AAPOS, 2007, 11 (06) :551-554
[3]   Intravitreal bevacizumab (Avastin) as primary and rescue treatment for choroidal neovascularization secondary to ocular toxoplasmosis [J].
Ben Yahia S. ;
Herbort C.P. ;
Jenzeri S. ;
Hmidi K. ;
Attia S. ;
Messaoud R. ;
Khairallah M. .
International Ophthalmology, 2008, 28 (4) :311-316
[4]   Toxoplasmosis-associated neovascular lesions treated successfully with ranibizumab and antiparasitic therapy [J].
Benevento, Joseph D. ;
Jager, Rama D. ;
Noble, A. Gwendolyn ;
Latkany, Paul ;
Mieler, William F. ;
Sautter, Mari ;
Meyers, Sanford ;
Mets, Marilyn ;
Grassi, Michael A. ;
Rabiah, Peter ;
Boyer, Kenneth ;
Swisher, Charles ;
McLeod, Rima .
ARCHIVES OF OPHTHALMOLOGY, 2008, 126 (08) :1152-1156
[5]   Prognostic factors for the long-term development of ocular lesions in 327 children with congenital toxoplasmosis [J].
Binquet, C ;
Wallon, M ;
Quantin, C ;
Kodjikian, L ;
Garweg, J ;
Fleury, J ;
Peyron, F ;
Abrahamowicz, M .
EPIDEMIOLOGY AND INFECTION, 2003, 131 (03) :1157-1168
[6]   OCULAR TOXOPLASMOSIS - CLINICAL ASPECT [J].
BLOCHMICHEL, E .
INTERNATIONAL OPHTHALMOLOGY, 1990, 14 (5-6) :353-357
[7]   Recurrent ocular disease in postnatally acquired toxoplasmosis [J].
Bosch-Driessen, EH ;
Rothova, A .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1999, 128 (04) :421-425
[8]   Ocular toxoplasmosis - Clinical features and prognosis of 154 patients [J].
Bosch-Driessen, LEH ;
Berendschot, TTJM ;
Ongkosuwito, JV ;
Rothova, A .
OPHTHALMOLOGY, 2002, 109 (05) :869-878
[9]   Retinal detachment in ocular toxoplasmosis [J].
Bosch-Driessen, LH ;
Karimi, S ;
Stilma, JS ;
Rothova, A .
OPHTHALMOLOGY, 2000, 107 (01) :36-40
[10]   Ophthalmic outcomes after prenatal and postnatal treatment of congenital toxoplasmosis [J].
Brézin, AP ;
Thulliez, P ;
Couvreur, J ;
Nobré, R ;
Mcleod, R ;
Mets, MB .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2003, 135 (06) :779-784